Healthcare  Name:  Sector:  Chief Executive: Anacor Healthcare David Perry  Summary: Biopharmaceutical company engaged in the discovery and development of novel antimicrobials for the treatment of serious bacterial and fungal infections.  Stage of Initial  Investment: Seed/Early  Liquidity: Private 1060 East Meadow Circle Palo Alto, CA 94303 Phone: 650.739.0700 Fax: 650.739.0139
	Copyright ©2007 Rho Capital Partners, Inc.